|
Q-Line Biotech Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
1254.71 Cr.
|
P/BV
|
5.31
|
Book Value (Rs.)
|
101.26
|
|
52 Week High/Low (Rs.)
|
600/431
|
FV/ML
|
10/400
|
P/E(X)
|
22.52
|
|
Bookclosure
|
|
EPS (Rs.)
|
23.89
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 197.94 | 143.80 |
| Total Income From Operations | 197.94 | 143.80 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 48.72 | 30.99 |
| Purchase of Traded Goods | 26.00 | 31.76 |
| Increase/Decrease in Stocks | -1.38 | -1.99 |
| Employees Cost | 24.06 | 15.99 |
| Depreciation | 6.70 | 4.09 |
| Other Expenses | 38.45 | 31.08 |
| Total Expenses | 142.56 | 111.92 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 55.38 | 31.88 |
| Other Income | 3.03 | 2.67 |
| P/L Before Interest, Excpt. Items & Tax | 58.41 | 34.55 |
| Interest | 11.11 | 8.31 |
| P/L Before Exceptional Items & Tax | 47.30 | 26.25 |
| P/L Before Tax | 47.30 | 26.25 |
| Tax | 11.90 | 4.93 |
| P/L After Tax from Ordinary Activities | 35.40 | 21.32 |
| Extra Ordinary Item | -0.99 | 0.00 |
| Net Profit/Loss For the Period | 34.41 | 21.32 |
| Net P/L After Minority Interest & Share Of Associates | 34.41 | 21.32 |
| | | |
| Equity Share Capital | 16.28 | 16.28 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 21.48 | 13.10 |
| Diluted EPS (Rs.) | 21.48 | 13.10 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 21.48 | 13.10 |
| Diluted EPS (Rs.) | 21.48 | 13.10 |
| | | |
| PBITOE Margin (%) | 27.97 | 22.16 |
| PBTE Margin (%) | 23.89 | 18.25 |
| PBT Margin (%) | 23.89 | 18.25 |
| PAT Margin (%) | 17.38 | 14.82 |
| PAT After MI And SOA Margin (%) | 17.38 | 14.82 |
